Contents of this document
- Consolidation of U.S. production into a single plant
- Reclassification of one consolidated subsidiary in Guangzhou, China as an equity-method affiliate through the transfer of the equity interest
- Closure of the Elizabethtown plant
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Net Sales | 1,601 Hundreds of millions of yen (YoY -1.0%) |
| Operating profit | 56 Hundreds of millions of yen |
| Ordinary income | 48 Hundreds of millions of yen |
| Net income | 18 Hundreds of millions of yen |
| Results for the three months of the current quarter | Net Sales 399 Hundreds of millions of yen / Operating profit 14 Hundreds of millions of yen |
| Full-year earnings forecast | Fiscal Period Covered Fiscal year ending March 2027 / Net Sales 1,409 Hundreds of millions of yen / Operating profit 70 Hundreds of millions of yen / Ordinary income 52 Hundreds of millions of yen / Profit before income taxes 50 Hundreds of millions of yen / Net income 25 Hundreds of millions of yen |
| Segment results | Japan Net Sales 648 Hundreds of millions of yen / Operating profit 45 Hundreds of millions of yen / North America Net Sales 493 Hundreds of millions of yen / Operating profit -32 Hundreds of millions of yen / Europe Net Sales 92 Hundreds of millions of yen / Operating profit 1 Hundreds of millions of yen / China Net Sales 127 Hundreds of millions of yen / Operating profit 11 Hundreds of millions of yen / ASEAN Net Sales 325 Hundreds of millions of yen / Operating profit 29 Hundreds of millions of yen / Asia Net Sales 452 Hundreds of millions of yen / Operating profit 40 Hundreds of millions of yen |
| Breakdown of Factors Affecting the Change | Revenue for the fiscal year ended March 2026 Changes in orders and other factors: -¥300 million; price changes: +¥2.2 billion; foreign exchange impact: -¥1.3 billion / Operating profit, fiscal year ended March 2026 Changes in orders: -¥900 million; labor costs: -¥1.2 billion; rationalization: +¥1.7 billion; expenses: +¥600 million; price changes: +¥2.2 billion; foreign exchange translation differences: ¥0 billion / Ordinary income for the fiscal year ended March 2026 Change in operating profit: +¥2.4 billion; foreign exchange gains and losses: +¥3.4 billion; financing costs: +¥1.7 billion; other: -¥500 million / Net income for the fiscal year ended March 2026 Change in ordinary profit: +¥7.1 billion; gain on sale of property, plant and equipment: +¥500 million; loss on sale of investment securities: -¥9.0 billion; income taxes: +¥200 million; deferred income taxes: +¥2.4 billion; other: +¥500 million |
| Assumptions Underlying the Business Outlook | Foreign Exchange USD 149.8⇒154.7 / EUR 175.6⇒174.9 / CNY 20.9⇒22.4 / THB 4.6⇒5.0 / IDR 0.0091⇒0.0093 |
| Financial targets | Equity ratio Fiscal year ended March 2025 38.6% / End of fiscal year ending March 2026 39.2% / Net debt-to-equity ratio Fiscal year ended March 2025 0.34x / End of fiscal year ending March 2026 0.34x |
| Capital expenditures | 46 Hundreds of millions of yen |
| New initiatives | Consolidation of U.S. production into a single plant, Reclassification of one consolidated subsidiary in Guangzhou, China as an equity-method affiliate through the transfer of the equity interest, Closure of the Elizabethtown plant |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Operating profit for the fiscal year ended March 2026 increased due to rationalization and expense reductions, passing raw material price increases and energy costs through to selling prices, an improvement in foreign exchange gains and losses, and a decrease in refinancing-related expenses incurred in the previous fiscal year. The decline in revenue expected for the fiscal year ending March 2027 is attributable to the consolidation of U.S. production into a single plant, the transfer of the equity interest in the Guangzhou, China subsidiary, and a decrease in orders, among other factors.